SINTX Technologies, Inc.

SINTX Technologies, Inc. is an advanced ceramics company headquartered in Salt Lake City, Utah, USA. The company is dedicated to the research, development, manufacturing, and commercialization of silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. Its core mission is to advance healing and human performance through the unique properties of silicon nitride.

SINTX Technologies' product portfolio includes monolithic solid silicon nitride, porous silicon nitride, silicon nitride powder (such as FleX SN-AP for antipathogenic applications), and silicon nitride coating products. They also specialize in silicon nitride composite materials, including SiN/PEEK biocomposites, for next-generation implants. These materials find applications in various medical fields, including spinal implants, dental implants, wound care, arthroplasty, medical personal protective equipment (PPE), and craniomaxillofacial procedures, as well as in industrial sectors like aerospace and electrical.

Led by CEO and Chairman Eric K. Olson, SINTX Technologies has been actively expanding its commercial footprint. Ryan Elmore was appointed President in March 2026 to spearhead commercial expansion efforts. The company reported a significant 199% increase in second-quarter 2026 revenue, driven by product sales and the early commercialization of its FDA-cleared SiNAPTIC® Foot & Ankle Osteotomy Wedge System, which received 510(k) clearance in October 2025. Additionally, SINTX secured approximately $3.2 million in new industrial purchase orders during the first half of 2026, signaling a strategic transition from a development-stage entity to a commercially focused biomaterials platform.